BURLINGTON, Mass., Nov. 12, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences in New York City in November.
The Company will present at the Stifel 2014 Healthcare Conference at the New York Palace Hotel on Tuesday, November 18, 2014. David Roberts, President, will provide an update on the Company at 2:25 pm EST. The Company will also present at the Canaccord Genuity Medical Technology Forum at the Westin Grand Central Hotel on Thursday, November 20, 2014, at 11:30 am EST and at the 2014 Brean Life Science Conference at the Millennium Broadway Hotel on Monday, November 24, 2014. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at these two conferences.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc.Sandra Millar
LeMaitre Vascular, Inc.